According to a new report published by UnivDatos Markets Insights, the liquid biopsy in cancer diagnostic market was valued at USD 7.5 billion in 2021 & is expected to grow at a CAGR of 10% from 2022-2028. The analysis has been segmented into Product (Instruments and Reagents & Kits); Sample (Blood, Urine, and Saliva); Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate...